Bardy Diagnostics fetches $35.5 mln Series B

Seattle-based Bardy Diagnostics Inc, a provider of ambulatory cardiac monitoring technologies and custom data solutions, has raised $35.5 million in Series B funding. River Cities Capital Funds led the round with participation from HealthQuest Capital, Aperture Venture Partners, Aphelion Capital, Lumira Ventures, Rex Health Ventures, SV Health Investors, Health Enterprise Partners and Ascension Ventures.

Source: Press Release